Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

This study has been completed.
Sponsor:
Information provided by:
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00621075
First received: January 17, 2008
Last updated: March 8, 2010
Last verified: March 2010
  Purpose

The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations.


Condition Intervention
Pulmonary Arterial Hypertension
Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

Resource links provided by NLM:


Further study details as provided by North Shore Long Island Jewish Health System:

Primary Outcome Measures:
  • The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 50
Study Start Date: April 2007
Study Completion Date: February 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Pulmonary Arterial Hypertension
Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans
Correlation of data from non-invasive tests such as lung perfusion scans with hemodynamic measurements
Other Name: Pulmonary Arterial Hypertension

Detailed Description:

Data collected from PAH patients who have had non-invasive Ventilation/Perfusion testing, Echocardiography, Chest CT Scan, Pulmonary Function Testing and the correlation of those results to the hemodynamic parameters Right Heart Catherization results and the various biomarkers.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pulmonary Arterial Hypertension

Criteria

Inclusion Criteria:

  • Pulmonary Arterial Hypertension

Exclusion Criteria:

  • Non-Pulmonary Arterial Hypertension
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00621075

Locations
United States, New York
North Shore-Lij Health System
New Hyde Park, New York, United States, 11040
Sponsors and Collaborators
North Shore Long Island Jewish Health System
Investigators
Principal Investigator: ARUNABH TALWAR, MD NORTH SHORE-LIJ HEALTH SYSTEM
  More Information

No publications provided

Responsible Party: ARUNABH TALWAR MD, NORTH SHORE-LONG ISLAND JEWIAH HEALTH SYSTEM
ClinicalTrials.gov Identifier: NCT00621075     History of Changes
Other Study ID Numbers: 07.014, NORTH SHORE IRB
Study First Received: January 17, 2008
Last Updated: March 8, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:
PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs

Additional relevant MeSH terms:
Hypertension
Hypertension, Pulmonary
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 23, 2014